Inhibikase Therapeutics develops drugs to treat lung and heart diseases, specifically focusing on a condition called pulmonary arterial hypertension. Their main product is an oral medication currently undergoing a global clinical trial to test its safety and effectiveness compared to existing treatments. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
